Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Telix Pharmaceuticals (NASDAQ: TLX) Gets FDA Approval for Pixclara Glioma Imaging Agent

Telix Pharmaceuticals Limited (NASDAQ: TLX) announced FDA approval of Pixclara (TLX101-CDx), marking the first targeted FET-PET agent cleared in the U.S. for glioma characterization across adult and pediatric populations.

Nitish Kishor | 15 September 2026

Tricor PMT25 Holdings Buys 525,000 CPI Card Group Shares

Tricor PMT25 Holdings Inc. bought 525,000 shares of CPI Card Group Inc (NASDAQ: PMTS). at $21.50 per share on 14 September 2026. The transaction was classified under SEC code P. The recorded price was $21.50 per share, and the transaction involved 525,000 shares.

Vinay Lochav | 15 September 2026

PDS Biotechnology (NASDAQ: PDSB) Rises 35% on Nant Capital-Led PIPE Financing

PDS Biotechnology Corporation (NASDAQ: PDSB) shares closed up 35% at $0.40 after the company completed the initial closing of an approximately $11.3 million PIPE led by Nant Capital.

Nitish Kishor | 15 September 2026

Dyadic International (NASDAQ: DYAI) Falls 13% on New Resale Prospectus

Dyadic International, Inc. (NASDAQ: DYAI) shares closed down 13% at $0.42 after the company submitted a resale prospectus registering up to 3.625 million shares for selling stockholders.

Nitish Kishor | 15 September 2026

Crown Castle (NYSE: CCI) Names Hinson CFO as Patel Retires

Crown Castle Inc. (NYSE: CCI) announced changes in senior leadership, with Chief Financial Officer Sunit Patel retiring and Chief Operating Officer Cathy Piche leaving the company. Kristoffer Hinson is intended to take over the finance post on April 1, 2027, while Crown Castle plans …

Vinay Lochav | 15 September 2026

Tyra Biosciences (NASDAQ: TYRA) Rises 14% on $400 Million Public Offering

Tyra Biosciences, Inc. (NASDAQ: TYRA) shares closed up 14% at $25.07 after the company announced the pricing of a $400 million underwritten public offering featuring common stock alongside pre-funded warrants at $22.03 per share equivalent, spearheaded by RACapitalalongside broad institutional backing.

Nitish Kishor | 15 September 2026

Cellectis (NASDAQ: CLLS) Falls 41% on Strategic Pivot to In Vivo Gene Editing

Cellectis S.A. (NASDAQ: CLLS) shares closed down 41% at $1.83 after the company announced a strategic pivot toward in vivo gene-editing programs, focusing resources on .HEAL-101 for APOC3 in severe hypertriglyceridemia and .HEAL-201 for PCSK9 in severe hypercholesterolemia.

Nitish Kishor | 15 September 2026

Cohn Adam Robert Exercises 5,998 VSE Corp Options

Cohn Adam Robert, chief financial officer of VSE CORP, exercised options for 5,998 shares on 11 September 2026. The option exercise was also recorded against 5,998 derivative securities.

Vinay Lochav | 15 September 2026

Corebridge Financial CIO Sells 8,736 Shares at $35 (NYSE: CRBG)

Corebridge Financial, Inc. (NYSE: CRBG) saw Chief Information Officer Ditillo David sell 8,736 shares at $35 per share on Sept. 11, 2026. The transaction was reported under code S.

Vinay Lochav | 15 September 2026

Adamo Claudine Receives 4,129 Costco Shares, Forfeits 917

Adamo Claudine received 4,129 shares of Costco Wholesale Corp (NASDAQ: COST) /New on 10 September 2026. Claudine is identified as the company’s executive vice president. A separate share forfeiture was recorded on the same date.

Vinay Lochav | 15 September 2026
Support

Hi! How can we help you today?

Loading…